Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Murphy

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
Chemical Senses|May 18, 2024
Integrating the patient's voice into the research agenda for treatment of chemosensory disordersClaire Murphy, Pamela Dalton, Katie Boateng, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 10, 2016
Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen CasesSira Nanthapisal, Claire Murphy, Ebun Omoyinmi, et al.
Medrxiv : the Preprint Server for Health Sciences|October 4, 2023
Patient Insights into the Diagnosis of Smell and Taste Disorders in the United StatesBita R Naimi, Stephanie R Hunter, Katie Boateng, et al.
BMJ Open|June 7, 2026
Randomised controlled feasibility trial of an intervention to increase activity and reduce sedentary behaviour in people with severe mental illness: Walking fOR Health (WORtH) studySuzanne M McDonough, Maurice Dillon, Catherine M McDonough, et al.
BJU International|April 13, 2007
Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): a new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomyChris Parker, Matthew R Sydes, Charles Catton, et al.
BMJ Open|December 27, 2023
ARCHERY: a prospective observational study of artificial intelligence-based radiotherapy treatment planning for cervical, head and neck and prostate cancer - study protocolAjay Aggarwal, Laurence Edward Court, Peter Hoskin, et al.
The Journal of Allergy and Clinical Immunology|November 28, 2019
Janus kinase inhibition for autoinflammation in patients with DNASE2 deficiencyYing Hong, Melania Capitani, Claire Murphy, et al.
Plos One|July 28, 2017
Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitisEbun Omoyinmi, Ariane Standing, Annette Keylock, et al.
Plos Biology|February 17, 2021
COVID-19 induces a hyperactive phenotype in circulating plateletsShane P Comer, Sarah Cullivan, Paulina B Szklanna, et al.
The Lancet. Oncology|March 4, 2014
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trialDavid P Dearnaley, Gordana Jovic, Isabel Syndikus, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
Chemical Senses|May 18, 2024
Integrating the patient's voice into the research agenda for treatment of chemosensory disordersClaire Murphy, Pamela Dalton, Katie Boateng, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 10, 2016
Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen CasesSira Nanthapisal, Claire Murphy, Ebun Omoyinmi, et al.
Medrxiv : the Preprint Server for Health Sciences|October 4, 2023
Patient Insights into the Diagnosis of Smell and Taste Disorders in the United StatesBita R Naimi, Stephanie R Hunter, Katie Boateng, et al.
BMJ Open|June 7, 2026
Randomised controlled feasibility trial of an intervention to increase activity and reduce sedentary behaviour in people with severe mental illness: Walking fOR Health (WORtH) studySuzanne M McDonough, Maurice Dillon, Catherine M McDonough, et al.
BJU International|April 13, 2007
Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): a new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomyChris Parker, Matthew R Sydes, Charles Catton, et al.
BMJ Open|December 27, 2023
ARCHERY: a prospective observational study of artificial intelligence-based radiotherapy treatment planning for cervical, head and neck and prostate cancer - study protocolAjay Aggarwal, Laurence Edward Court, Peter Hoskin, et al.
The Journal of Allergy and Clinical Immunology|November 28, 2019
Janus kinase inhibition for autoinflammation in patients with DNASE2 deficiencyYing Hong, Melania Capitani, Claire Murphy, et al.
Plos One|July 28, 2017
Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitisEbun Omoyinmi, Ariane Standing, Annette Keylock, et al.
Plos Biology|February 17, 2021
COVID-19 induces a hyperactive phenotype in circulating plateletsShane P Comer, Sarah Cullivan, Paulina B Szklanna, et al.
The Lancet. Oncology|March 4, 2014
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trialDavid P Dearnaley, Gordana Jovic, Isabel Syndikus, et al.
Pageof 16